Investors & Research Partners

InVitvo Pharmaceuticals

Founded in Edmonton in 2021, InVitvo isolates, purifies, and characterizes compounds from microorganisms. Its current commercial offering is Terrein for laboratory research.

Current business

InVitvo offers research compounds to academic laboratories, pharmaceutical R&D teams, and contract research organizations. Terrein is listed in 5 mg and 10 mg quantities; custom quantities are quoted individually.

Review the Terrein offering

Scientific focus

The research focus is microbial secondary metabolites from Canadian environmental sources, including Terrein and its derivatives. Products are supplied for research use only; laboratory literature does not establish clinical effectiveness.

Explore the research context

Meet the scientific team

InVitvo is led by founder Anooshirvan Shayeganpour, Ph.D., and co-founder Heidi Rashidi, Pharm.D.

Team backgrounds

Start a conversation

Contact the team to discuss investment or research collaboration, including current development priorities, analytical evidence, and commercial plans.

Investment inquiry Research collaboration inquiry